Anti-MCV in RA-ILD: New Insights into Diagnosis and Clinical Relevance
Insights into anti-MCV as a potential marker of pulmonary involvement in RA.
- RA-ILD is a serious complication of rheumatoid arthritis, with early identification of pulmonary involvement remaining an important clinical challenge.
- Anti-MCV antibodies may provide valuable insights into RA-associated lung disease, potentially complementing established serological and clinical markers.
- This scoping review examines the current evidence on the diagnostic and clinical significance of anti-MCV antibodies in patients with RA-ILD and highlights the need for prospective validation.
Test associated with this resource
Related instrument
Any assay, any sample, any time!
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country. Please contact your local Sebia representative. Information intended for healthcare professionals. Carefully read the instructions in the reagent package inserts and instrument manuals.